Work

Obatoclax in Combination with Fludarabine and Rituximab (FR) Is Well-Tolerated and Shows Promising Clinical Activity in Relapsed CLL/SLL

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.2865.2865

Authors: Jennifer R Brown, Bethany Tesar, Lillian Werner, Evgeny Mikler, Hazel Reynolds, Christina Thompson, David C. Fisher, Naoko Takebe, Donna Neuberg, Arnold S. Freedman

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, National Institutes of Health, National Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556946213

FWCI: 1.013

Cites:

Cited by: 8

Related to: 10